Eaton Vance Management Collegium Pharmaceutical, Inc Transaction History

Eaton Vance Management

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$17.2 - $22.5 $1,565 - $2,047	-91 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$17.5 - $21.35 $1,592 - $1,942	91 New	91 $0
Q3 2021 Nov 15, 2021	SELL	$17.75 - $25.39 $6,958 - $9,952	-392 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$21.74 - $25.28 $6,304 - $7,331	290 Added 284.31%	392 $9,000
Q1 2021 May 17, 2021	BUY	$19.25 - $26.1 $1,963 - $2,662	102 New	102 $2,000

255

36.9M

100K

21.1K

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1.01B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

Get notified when there are updates to the investment portfolio of Eaton Vance Management, based on Form 13F filings with the SEC.

Stay updated on Eaton Vance Management with notifications on news.